Current status of antitumor therapy with monoclonal antibodies - PubMed (original) (raw)

Affiliations

Review

Current status of antitumor therapy with monoclonal antibodies

D A Scheinberg et al. Oncology (Williston Park). 1987 May.

Abstract

The potential power of monoclonal antibodies arises from their ability to recognize single antigenic determinants in a complex mixture of molecules or cells. The possibilities for cancer therapy are apparent. But to what extent has the potential been realized? What problems have arisen in clinical trials?

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources